RZLT Stock Analysis: Buy, Sell, or Hold?
RZLT - Rezolute, Inc. Common Stock (NV)
$5.09
0.43 (9.23%)
▲
5d:
+10.65%
30d:
-4.14%
90d:
+52.4%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Sep 16, 2026
22d
Get Alerted When RZLT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: RZLT shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: RZLT shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: RZLT is currently trading at $5.09, which is considered extended relative to its 30-day fair value range of $4.58 to $4.97.
Technical Outlook: Technically, RZLT is in a strong uptrend. Immediate support is located at $4.44, while resistance sits at $5.63. The stock is showing strong short-term momentum, up 9.2% recently.
Market Sentiment: RZLT scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.67 (+50.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RZLT is in a strong uptrend. Immediate support is located at $4.44, while resistance sits at $5.63. The stock is showing strong short-term momentum, up 9.2% recently.
Market Sentiment: RZLT scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.67 (+50.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$4.58 -
$4.97
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
31.6%
Protect Your Profits
Holding RZLT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+9.2%)
- BULLISH: Trading 50.6% below Wall St target ($7.67)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$4.58 -
$4.97
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.44
Resistance Level
$5.64
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.13
Wall Street Target
$7.67
(+50.6%)
Share & Embed Analysis
Last updated: August 23, 2026 11:19 PM ET
Data refreshes hourly during market hours. Next update: 12:19 AM
Data refreshes hourly during market hours. Next update: 12:19 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RZLT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 42 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 66 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 50 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$108 | 52 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
10 analysts |
$138 | 66 BUY |
Advanced RZLT Option Strategies
Professional options setups generated by AI based on today's RZLT price and gamma walls.
